Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Pietro Crispino, Tiziana Ciarambino & Mauro Giordano. (2023) Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens. Current Issues in Molecular Biology 45:6, pages 4701-4715.
Crossref
Crossref
In Ji SongHyun Ki KimNa Keum LeeSang Kil Lee. (2018) Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis. Yonsei Medical Journal 59:8, pages 951.
Crossref
Crossref
Francisco Baldaque-Silva, Michael Vieth, Mumen Debel, Bengt Håkanson, Anders Thorell, Nuno Lunet, Huan Song, Miguel Mascarenhas-Saraiva, Gisela Pereira, Lars Lundell & Hanns-Ulrich Marschall. (2017) Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World Journal of Gastroenterology 23:17, pages 3174.
Crossref
Crossref
Kirthi R. Kumar, Ramiz Iqbal, Elizabeth Coss, Christina Park, Byron Cryer & Robert M. Genta. (2013) Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors. Human Pathology 44:12, pages 2706-2710.
Crossref
Crossref
Jens Krugmann, Helmut Neumann, Michael Vieth & David Armstrong. (2013) What is the role of endoscopy and oesophageal biopsies in the management of GERD?. Best Practice & Research Clinical Gastroenterology 27:3, pages 373-385.
Crossref
Crossref
Tiberiu Hershcovici, Choo H. Poh, Ofer Z. Fass, Nicole Ashpole, Yasutada Akiba, Jose M. Guillén‐Rodríguez, Jonathan D. Kaunitz & Ronnie Fass. (2011)
Oesophageal sensation in response to high PCO
2
and acidic solutions in nonerosive reflux disease
. European Journal of Clinical Investigation 42:2, pages 195-202.
Crossref
Crossref
. (2011) Doença do refluxo gastroesofágico: diagnóstico. Revista da Associação Médica Brasileira 57:5, pages 499-507.
Crossref
Crossref
. (2011) Gastroesophageal reflux disease: diagnosis. Revista da Associação Médica Brasileira (English Edition) 57:5, pages 489-497.
Crossref
Crossref
. (2011) Gastroesophageal reflux disease: diagnosis. Revista da Associação Médica Brasileira 57:5, pages 489-497.
Crossref
Crossref
Roberto Fiocca, Luca Mastracci, Cecilia Engström, Stephen Attwood, Christian Ell, Jean-Paul Galmiche, Jan Hatlebakk, Ola Junghard, Tore Lind & Lars Lundell. (2010) Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial. American Journal of Gastroenterology 105:5, pages 1015-1023.
Crossref
Crossref
Joaquim Prado P. Moraes-Filho, Tomas Navarro-Rodriguez, Ricardo Barbuti, Jaime Eisig, Decio Chinzon & Wanderley Bernardo. (2010) Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arquivos de Gastroenterologia 47:1, pages 99-115.
Crossref
Crossref
Roberto Fiocca, Luca Mastracci, Robert Riddell, Kaiyo Takubo, Michael Vieth, Lisa Yerian, Prateek Sharma, Paula Fernström & Magnus Ruth. (2010) Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Human Pathology 41:2, pages 223-231.
Crossref
Crossref
Jonathan RE Rees, Pierre Lao-Sirieix, Angela Wong & Rebecca C Fitzgerald. (2010) Treatment for Barrett's oesophagus. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Michael Vieth. (2008) Contribution of histology to the diagnosis of reflux disease. Best Practice & Research Clinical Gastroenterology 22:4, pages 625-638.
Crossref
Crossref
André Duranceau. (2008) Gastroesophageal Reflux. The Annals of Thoracic Surgery 85:3, pages 1135-1137.
Crossref
Crossref
Shinichiro Mine, Takeshi Iida, Takahiro Tabata, Yosuke Okada & Yoshiya Tanaka. (2007) Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: Normalization by treatment with a proton pump inhibitor. Journal of Gastroenterology and Hepatology 23:2, pages 303-309.
Crossref
Crossref
L. C. HILLMAN, L. CHIRAGAKIS, B. SHADBOLT, G. L. KAYE & A. C. CLARKE. (2007) Effect of proton pump inhibitors on markers of risk for high‐grade dysplasia and oesophageal cancer in Barrett’s oesophagus. Alimentary Pharmacology & Therapeutics 27:4, pages 321-326.
Crossref
Crossref
W. A. Simon, M. Herrmann, T. Klein, J. M. Shin, R. Huber, J. Senn-Bilfinger & S. Postius. (2007) Soraprazan: Setting New Standards in Inhibition of Gastric Acid Secretion. Journal of Pharmacology and Experimental Therapeutics 321:3, pages 866-874.
Crossref
Crossref
John Dent. (2007) Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease. Clinical Gastroenterology and Hepatology 5:1, pages 4-16.e1.
Crossref
Crossref
Michael Vieth, Ralf Kiesslich, Kaiyo Takubo & Manfred Stolte. (2006) Recent trends in GERD: problems of diagnosis and treatment. Esophagus 3:3, pages 95-104.
Crossref
Crossref
Masanori Toyoda, Daisuke Shirasaka, Nobuo Aoyama, Yoshinori Watanabe, Ikuya Miki, Yoshinori Morita, Yuko Matsumoto, Toshifumi Mitani, Hideyuki Miyachi, Takao Tamura & Masato Kasuga. (2006)
Impact of
Helicobacter pylori
Eradication Therapy on Histologic Change in the Distal Esophagus
. Helicobacter 11:4, pages 217-223.
Crossref
Crossref
Steven J. Steiner, Kevin M. Kernek & Joseph F. Fitzgerald. (2006) Severity of Basal Cell Hyperplasia Differs in Reflux Versus Eosinophilic Esophagitis. Journal of Pediatric Gastroenterology and Nutrition 42:5, pages 506-509.
Crossref
Crossref
M. VIETH, M. KULIG, A. LEODOLTER, E. NAUCLÉR, D. JASPERSEN, J. LABENZ, W. MEYER‐SABELLEK, T. LIND, S. WILLICH, P. MALFERTHEINER & M. STOLTE. (2005) Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus. Alimentary Pharmacology & Therapeutics 23:2, pages 313-319.
Crossref
Crossref
Mogens Bove, Michael Vieth, Frank Dombrowski, Lars Ny, Magnus Ruth & Lars Lundell. (2005) Acid Challenge to the Human Esophageal Mucosa: Effects on Epithelial Architecture in Health and Disease. Digestive Diseases and Sciences 50:8, pages 1488-1496.
Crossref
Crossref
Katherine F Croom & Lesley J Scott. (2005) Lansoprazole. Drugs 65:15, pages 2129-2135.
Crossref
Crossref
L. G. M. van Rossum, R. J. F. Laheij, F. Vlemmix, J. B. M. J. Jansen & F. W. A. Verheugt. (2004) Health‐related quality of life in patients with cardiovascular disease – the effect of upper gastrointestinal symptom treatment. Alimentary Pharmacology & Therapeutics 19:10, pages 1099-1104.
Crossref
Crossref
R. Kiesslich, S. Kanzler, M. Vieth, M. Moehler, J. Neidig, B.J. Thanka Nadar, D. Schilling, J. Burg, B. Nafe, M.F. Neurath & P.R. Galle. (2004) Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy. Digestive Diseases 22:2, pages 221-227.
Crossref
Crossref
M. Vieth, U. Peitz, J. Labenz, M. Kulig, E. Nauclér, D. Jaspersen, W. Meyer-Sabellek, S. Willich, T. Lind, P. Malfertheiner & M. Stolte. (2004) What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa?. Digestive Diseases 22:2, pages 196-201.
Crossref
Crossref
Lesley J. Scott. (2003) Lansoprazole. Pediatric Drugs 5:1, pages 57-61.
Crossref
Crossref